Initiated Clinical Trials

Bone/Osteoporosis

Clinical studies on Lilly products may also be sponsored and reported by parties other than Lilly in other clinical trial registries.

The following trials have been initiated for compounds in the osteoporosis therapeutic area.

Indication	Trial ID	Trial Description
Arthritis, Rheumatoid	8705	A Safety and Pharmacokinetics Study in Patients with Rheumatoid Arthritis
Colles' Fracture	8175	Effects of Teriparatide on Distal Radius Fracture Healing
Glucocorticoid Induced Osteoporosis	11716	Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis
Osteoporosis	10591	A Study for Patients with Osteoporosis
Osteoporosis	10494	Phase 3 Clinical Trial of Teriparatide in Japan
Osteoporosis	10586	Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy
Osteoporosis	6484	Comparison of Teriparatide With Alendronate on How it Effects Glucocorticoid-Induced Osteoporosis
Osteoporosis	9917	Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women with Osteoporosis
Osteoporosis	7918	Bone Effects of Teriparatide Following Alendronate
Osteoporosis	8370	Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients
Osteoporosis	8464	Clinical Trial of Teriparatide in Japan
Osteoporosis	9151	Teriparatide Use in Hip Replaced Subjects
Osteoporosis, Postmenopausal	547	Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Osteoporosis, Postmenopausal	6972	A Study of the Treatment of Postmenopausal Women With Osteoporosis
Osteoporosis, Postmenopausal	6680	Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
Osteoporosis, Postmenopausal	8536	Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer
Osteoporosis, Postmenopausal	6573	PTH Comparison in Post Menopausal Women
Osteoporosis, Postmenopausal	5490	Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women with Osteoporosis
Osteoporosis, Postmenopausal	6537	2-year Therapy with Teriparatide vs 1-yr Therapy followed by 1-year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
Osteoporosis, Postmenopausal	6715	Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
Osteoporosis, Postmenopausal	11996	A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide
Osteoporosis, Postmenopausal	1363	Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis (MORE)
Osteoporosis, Postmenopausal	8135	Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo
Osteoporosis, Postmenopausal	8149	Long Term Effects of Raloxifene Treatment on Bone Quality
Osteoporosis, Postmenopausal	8736	Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Postmenopausal Bone Loss	8537	Effects of Arzoxifene on Bone Mass and the Uterus
Postmenopausal Osteoporosis Back Pain Spinal Fracture	9041	Effect of Teriparatide Compared to Risedronate on Back Pain in Women with a Spine Fracture Caused by Osteoporosis
Postmenopausal Osteoporosis	8580	Study Comparing Arzoxifene with Raloxifene in Women After Menopause with Osteoporosis
Postmenopausal Osteoporosis	10080	Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
Postmenopausal Osteoporosis	8141	Effects of Teriparatide in Postmenopausal Women with Osteoporosis
Rheumatoid Arthritis	11351	A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy
Rheumatoid Arthritis	11055	A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Patients with Rheumatoid Arthritis